MAGic BioProcessing Expands Team with New Director of Sales for North America East

MAGic BioProcessing Welcomes a New Team Member

In a significant development for the biotech industry, MAGic BioProcessing has appointed Ben Krol as the Director of Sales & Business Development for North America East. This exciting news comes from the company's headquarters, with the team expressing their enthusiasm about the new addition.

Ben has joined MAGic BioProcessing from Ecolab, where he accumulated extensive experience in chromatography resins. His robust background will not only propel the sales strategy for MAGic but also contribute to the company's ongoing commitment to innovation in bioprocessing technologies.

Krol's deep understanding of the evolving landscape in the biotechnology and pharmaceutical sectors positions him perfectly to address the complex needs of today’s market. His insights into downstream processing are expected to be instrumental in driving forward MAGic’s sales initiatives and aligning technological advancements with industry demands. At MAGic, the focus is on developing proprietary magnetic-based products and methodologies specifically designed for the bioprocessing of biologics, which includes recombinant proteins, monoclonal antibodies, viral vectors, and cells.

MAGic BioProcessing is headquartered in Uppsala, Sweden and operates under the principles of excellence and innovation, empowering researchers and industry professionals alike. The company's commitment to providing cutting-edge solutions ensures that they remain at the forefront of the biotech industry.

As Krol steps into his new role, all eyes are on MAGic BioProcessing to see how his leadership will shape the company’s trajectory in North America. The combination of Krol’s expertise and MAGic's innovative spirit promises to enhance their market presence and the quality of service provided to clients.

This appointment is part of a broader trend within the biotech sector, where companies are continually seeking to deepen their expertise and expand their market reach. The strategic hire underscores the importance of adapting to the rapid changes in bioprocessing technologies and the increasing demands from the pharmaceutical industry.

For additional inquiries or detailed information regarding MAGic BioProcessing and their innovative technologies, please contact Peter Karlberg, the CEO, via email at email protected] Alternatively, more information can be found on the MAGic BioProcessing website at [magicbioprocessing.com.

As the biotech landscape continues to evolve, the industry looks forward to seeing how this new appointment will impact MAGic’s capabilities and the broader market in North America. The future appears bright for MAGic BioProcessing with the inclusion of Ben Krol, a professional who embodies the drive for excellence and understanding essential for success in today’s rapidly advancing biotechnology field.